An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use
There are now 9 available FDA-approved second-generation long-acting injectable antipsychotics including aripiprazole (3), olanzapine (1), paliperidone (3), and risperidone (2). These high-cost medications are commonly used with the goal of improving adherence and patient outcomes. With almost 2 dec...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Association of Psychiatric Pharmacists
2022-11-01
|
| 叢編: | Mental Health Clinician |
| 主題: | |
| 在線閱讀: | https://theijpt.org/doi/pdf/10.9740/mhc.2022.10.270 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
